Association of Clinicopathological Features With Locoregional Recurrence and Disease Outcomes Among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Ethiopia: A Hospital-Based Retrospective Cohort Study
- 1Department of Pathology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- 2Department of Anatomic Pathology, Onco-Pathology Diagnostic Center, Addis Ababa, Ethiopia
Abstract
Introduction: The clinicopathological features of breast cancer (BC) influence treatment decisions and disease prognosis. Locoregional recurrence is frequently observed among BC patients despite the availability of several treatment options. The objective of this study was to determine the association of clinicopathological features with locoregional recurrence and disease outcomes of female BC patients in Tikur Anbessa Specialized Hospital (TASH), Ethiopia.
Methods: A hospital-based retrospective cohort study was conducted on 258 female BC patients treated at TASH between September 2017 and September 2020. Data were extracted from the patients’ charts using Kobo Toolbox and analyzed using SPSS version 26. Median time to recurrence was estimated, and recurrence-free survival (RFS) was assessed using Kaplan–Meier survival analysis. Life-table methods were used to estimate survival probabilities over the follow-up period. The assumptions of cox proportional hazard were checked, and variables were analyzed in bivariate and multivariable Cox proportional hazard model. Adjusted Hazard Ratio (AHR) with 95% CI was calculated for the significant predictive variables and statistical significance was declared at p-value<0.05.
Result: The majority of BC patients presented with clinical stage II or III disease, with a median age of 40 years. The incidence rate of BC recurrence was 5.36 per 100 person-years (95%CI=3.85-7.07). The median recurrence free survival (RFS) was 55 months (95% CI=41.73-68.26). The proportion of RFS at 12, 24, and 60 months were 92.5%, 81.4%, and 41.7%, respectively. Histologic grade III (AHR=3.22, 95% CI (1.37-7.6)), and lymph node involvement (AHR=1.175, 95%CI, (1.11-1.27)) were independent predictors of increased risk of breast cancer recurrence.
Conclusion: There was a high incidence of locoregional recurrence among BC patients. Pathological variables, including histologic grade and lymph node involvement, may help predict the risk of breast cancer recurrence and should be considered in breast cancer management.
Related
- Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study
- Transverse colon cancer as an independent predictor of locoregional recurrence in patients with stage III colon cancer: a retrospective cohort study.
- A nomogram integrating YTHDC2 expression and clinicopathological parameters for predicting endometrial cancer recurrence: a multicenter retrospective study
- Study on the association between the low-density lipoprotein to high-density lipoprotein ratio and clinicopathological characteristics of breast cancer: A retrospective analysis incorporating subgroup evaluations by age, body mass index, and menopausal status
- Association of ABO and Rh blood groups with clinicopathological features and lymph node involvement in surgically treated thyroid malignancies: a retrospective single-center study.
BibTeX
@article{mohammed2026association,
title = {{Association of Clinicopathological Features With Locoregional Recurrence and Disease Outcomes Among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Ethiopia: A Hospital-Based Retrospective Cohort Study}},
author = {Hidaya Yahya Mohammed and Isa Salo Abdo and Yonas Girma Shumiye and Wajana Lako Labisso},
journal = {Cancer Control: Journal of the Moffitt Cancer Center},
year = {2026},
month = sep,
doi = {10.1177/10732748261491904},
url = {https://doi.org/10.1177/10732748261491904},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Association of Clinicopathological Features With Locoregional Recurrence and Disease Outcomes Among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Ethiopia: A Hospital-Based Retrospective Cohort Study
AU - Hidaya Yahya Mohammed
AU - Isa Salo Abdo
AU - Yonas Girma Shumiye
AU - Wajana Lako Labisso
PY - 2026
DA - 2026/09/21
JO - Cancer Control: Journal of the Moffitt Cancer Center
DO - 10.1177/10732748261491904
UR - https://doi.org/10.1177/10732748261491904
AB - Introduction: The clinicopathological features of breast cancer (BC) influence treatment decisions and disease prognosis. Locoregional recurrence is frequently observed among BC patients despite the availability of several treatment options. The objective of this study was to determine the association of clinicopathological features with locoregional recurrence and disease outcomes of female BC patients in Tikur Anbessa Specialized Hospital (TASH), Ethiopia. Methods: A hospital-based retrospective cohort study was conducted on 258 female BC patients treated at TASH between September 2017 and September 2020. Data were extracted from the patients’ charts using Kobo Toolbox and analyzed using SPSS version 26. Median time to recurrence was estimated, and recurrence-free survival (RFS) was assessed using Kaplan–Meier survival analysis. Life-table methods were used to estimate survival probabilities over the follow-up period. The assumptions of cox proportional hazard were checked, and variables were analyzed in bivariate and multivariable Cox proportional hazard model. Adjusted Hazard Ratio (AHR) with 95% CI was calculated for the significant predictive variables and statistical significance was declared at p-value<0.05. Result: The majority of BC patients presented with clinical stage II or III disease, with a median age of 40 years. The incidence rate of BC recurrence was 5.36 per 100 person-years (95%CI=3.85-7.07). The median recurrence free survival (RFS) was 55 months (95% CI=41.73-68.26). The proportion of RFS at 12, 24, and 60 months were 92.5%, 81.4%, and 41.7%, respectively. Histologic grade III (AHR=3.22, 95% CI (1.37-7.6)), and lymph node involvement (AHR=1.175, 95%CI, (1.11-1.27)) were independent predictors of increased risk of breast cancer recurrence. Conclusion: There was a high incidence of locoregional recurrence among BC patients. Pathological variables, including histologic grade and lymph node involvement, may help predict the risk of breast cancer recurrence and should be considered in breast cancer management.
SN - 1073-2748
SN - 1526-2359
ER -